HEADER TRANSFERASE/TRANSFERASE INHIBITOR 09-SEP-16 5TA8 TITLE CRYSTAL STRUCTURE OF PLK1 IN COMPLEX WITH A NOVEL 5,6- TITLE 2 DIHYDROIMIDAZOLO[1,5-F]PTERIDINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 13-345; COMPND 5 SYNONYM: POLO-LIKE KINASE 1,PLK-1,SERINE/THREONINE-PROTEIN KINASE 13, COMPND 6 STPK13; COMPND 7 EC: 2.7.11.21; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PLK1, PLK; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PFASTBACHTB KEYWDS PLK1 INHIBITOR, KINASE, STRUCTURE-BASED DRUG DESIGN, ANTITUMOR KEYWDS 2 ACTIVITY, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.SKENE,D.J.HOSFIELD REVDAT 3 06-MAR-24 5TA8 1 REMARK REVDAT 2 08-MAR-17 5TA8 1 JRNL REVDAT 1 22-FEB-17 5TA8 0 JRNL AUTH A.KIRYANOV,S.NATALA,B.JONES,C.MCBRIDE,V.FEHER,B.LAM,Y.LIU, JRNL AUTH 2 K.HONDA,N.UCHIYAMA,T.KAWAMOTO,Y.HIKICHI,L.ZHANG,D.HOSFIELD, JRNL AUTH 3 R.SKENE,H.ZOU,J.STAFFORD,X.CAO,T.ICHIKAWA JRNL TITL STRUCTURE-BASED DESIGN AND SAR DEVELOPMENT OF JRNL TITL 2 5,6-DIHYDROIMIDAZOLO[1,5-F]PTERIDINE DERIVATIVES AS NOVEL JRNL TITL 3 POLO-LIKE KINASE-1 INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 1311 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28169164 JRNL DOI 10.1016/J.BMCL.2016.10.009 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0025 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 76.1 REMARK 3 NUMBER OF REFLECTIONS : 9290 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 465 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 245 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 28.28 REMARK 3 BIN R VALUE (WORKING SET) : 0.2890 REMARK 3 BIN FREE R VALUE SET COUNT : 14 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2379 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 43 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 94.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.39000 REMARK 3 B22 (A**2) : 6.39000 REMARK 3 B33 (A**2) : -9.59000 REMARK 3 B12 (A**2) : 3.20000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.368 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.305 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 31.645 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2477 ; 0.006 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3347 ; 1.086 ; 2.000 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 293 ; 5.470 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 109 ;31.195 ;22.385 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 449 ;17.952 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;14.687 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 365 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1846 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 38 A 90 REMARK 3 RESIDUE RANGE : A 91 A 137 REMARK 3 ORIGIN FOR THE GROUP (A): 6.932 27.456 58.657 REMARK 3 T TENSOR REMARK 3 T11: 0.4561 T22: 0.3219 REMARK 3 T33: 0.1083 T12: 0.1548 REMARK 3 T13: 0.0706 T23: 0.0469 REMARK 3 L TENSOR REMARK 3 L11: 2.1590 L22: 3.5981 REMARK 3 L33: 5.9581 L12: -1.0073 REMARK 3 L13: -2.3730 L23: 1.0107 REMARK 3 S TENSOR REMARK 3 S11: -0.1621 S12: 0.0147 S13: -0.0626 REMARK 3 S21: -0.3216 S22: -0.1361 S23: -0.1207 REMARK 3 S31: 0.9977 S32: 0.7788 S33: 0.2982 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 4 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 138 A 190 REMARK 3 RESIDUE RANGE : A 191 A 240 REMARK 3 RESIDUE RANGE : A 241 A 291 REMARK 3 RESIDUE RANGE : A 292 A 330 REMARK 3 ORIGIN FOR THE GROUP (A): -13.098 39.365 70.373 REMARK 3 T TENSOR REMARK 3 T11: 0.1674 T22: 0.3377 REMARK 3 T33: 0.1211 T12: 0.0587 REMARK 3 T13: -0.0368 T23: -0.0951 REMARK 3 L TENSOR REMARK 3 L11: 2.8859 L22: 3.5659 REMARK 3 L33: 8.4001 L12: -0.1783 REMARK 3 L13: -0.7255 L23: 0.4409 REMARK 3 S TENSOR REMARK 3 S11: 0.1998 S12: 0.1730 S13: 0.0006 REMARK 3 S21: -0.3636 S22: -0.3213 S23: 0.4313 REMARK 3 S31: -0.3952 S32: -0.9703 S33: 0.1215 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5TA8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000223815. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-OCT-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9764 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 75.9 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 28.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.24700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.95 MM SUCCINIC ACID, 1.7% PEG2000 REMARK 280 MME, 0.4 MM ZINC ACETATE, 100 MM HEPES, PH 7.0, TEMPERATURE 277K, REMARK 280 VAPOR DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 101.27867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 50.63933 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 50.63933 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 101.27867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 539 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -12 REMARK 465 SER A -11 REMARK 465 TYR A -10 REMARK 465 TYR A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 ASP A -2 REMARK 465 TYR A -1 REMARK 465 ASP A 0 REMARK 465 ILE A 1 REMARK 465 PRO A 2 REMARK 465 THR A 3 REMARK 465 THR A 4 REMARK 465 GLU A 5 REMARK 465 ASN A 6 REMARK 465 LEU A 7 REMARK 465 TYR A 8 REMARK 465 PHE A 9 REMARK 465 GLN A 10 REMARK 465 GLY A 11 REMARK 465 ALA A 12 REMARK 465 ALA A 13 REMARK 465 PRO A 14 REMARK 465 ALA A 15 REMARK 465 ASP A 16 REMARK 465 PRO A 17 REMARK 465 GLY A 18 REMARK 465 LYS A 19 REMARK 465 ALA A 20 REMARK 465 GLY A 21 REMARK 465 VAL A 22 REMARK 465 PRO A 23 REMARK 465 GLY A 24 REMARK 465 VAL A 25 REMARK 465 ALA A 26 REMARK 465 ALA A 27 REMARK 465 PRO A 28 REMARK 465 GLY A 29 REMARK 465 ALA A 30 REMARK 465 PRO A 31 REMARK 465 ALA A 32 REMARK 465 ALA A 33 REMARK 465 ALA A 34 REMARK 465 PRO A 35 REMARK 465 PRO A 36 REMARK 465 SER A 331 REMARK 465 LEU A 332 REMARK 465 ASP A 333 REMARK 465 PRO A 334 REMARK 465 SER A 335 REMARK 465 ASN A 336 REMARK 465 ARG A 337 REMARK 465 LYS A 338 REMARK 465 PRO A 339 REMARK 465 LEU A 340 REMARK 465 THR A 341 REMARK 465 VAL A 342 REMARK 465 LEU A 343 REMARK 465 ASN A 344 REMARK 465 LYS A 345 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 38 63.39 73.23 REMARK 500 ASP A 74 -62.03 -96.92 REMARK 500 ALA A 109 116.24 -161.52 REMARK 500 ASP A 122 -161.54 -110.51 REMARK 500 ARG A 136 -117.67 65.04 REMARK 500 LYS A 146 -131.88 60.67 REMARK 500 ARG A 175 -11.97 72.53 REMARK 500 ASP A 194 90.37 51.52 REMARK 500 PHE A 195 41.30 -96.67 REMARK 500 TYR A 217 63.91 -102.99 REMARK 500 SER A 229 -141.74 -142.44 REMARK 500 GLU A 231 -4.03 -55.19 REMARK 500 GLU A 252 110.31 -2.03 REMARK 500 ASN A 266 79.21 51.26 REMARK 500 HIS A 273 0.69 -68.46 REMARK 500 LEU A 286 58.02 -94.70 REMARK 500 THR A 291 0.89 -68.56 REMARK 500 PRO A 329 -148.25 -69.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 543 DISTANCE = 6.38 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 212 SG REMARK 620 2 CYS A 255 SG 111.8 REMARK 620 N 1 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 79C A 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TA6 RELATED DB: PDB DBREF 5TA8 A 13 345 UNP P53350 PLK1_HUMAN 13 345 SEQADV 5TA8 MET A -12 UNP P53350 INITIATING METHIONINE SEQADV 5TA8 SER A -11 UNP P53350 EXPRESSION TAG SEQADV 5TA8 TYR A -10 UNP P53350 EXPRESSION TAG SEQADV 5TA8 TYR A -9 UNP P53350 EXPRESSION TAG SEQADV 5TA8 HIS A -8 UNP P53350 EXPRESSION TAG SEQADV 5TA8 HIS A -7 UNP P53350 EXPRESSION TAG SEQADV 5TA8 HIS A -6 UNP P53350 EXPRESSION TAG SEQADV 5TA8 HIS A -5 UNP P53350 EXPRESSION TAG SEQADV 5TA8 HIS A -4 UNP P53350 EXPRESSION TAG SEQADV 5TA8 HIS A -3 UNP P53350 EXPRESSION TAG SEQADV 5TA8 ASP A -2 UNP P53350 EXPRESSION TAG SEQADV 5TA8 TYR A -1 UNP P53350 EXPRESSION TAG SEQADV 5TA8 ASP A 0 UNP P53350 EXPRESSION TAG SEQADV 5TA8 ILE A 1 UNP P53350 EXPRESSION TAG SEQADV 5TA8 PRO A 2 UNP P53350 EXPRESSION TAG SEQADV 5TA8 THR A 3 UNP P53350 EXPRESSION TAG SEQADV 5TA8 THR A 4 UNP P53350 EXPRESSION TAG SEQADV 5TA8 GLU A 5 UNP P53350 EXPRESSION TAG SEQADV 5TA8 ASN A 6 UNP P53350 EXPRESSION TAG SEQADV 5TA8 LEU A 7 UNP P53350 EXPRESSION TAG SEQADV 5TA8 TYR A 8 UNP P53350 EXPRESSION TAG SEQADV 5TA8 PHE A 9 UNP P53350 EXPRESSION TAG SEQADV 5TA8 GLN A 10 UNP P53350 EXPRESSION TAG SEQADV 5TA8 GLY A 11 UNP P53350 EXPRESSION TAG SEQADV 5TA8 ALA A 12 UNP P53350 EXPRESSION TAG SEQADV 5TA8 VAL A 210 UNP P53350 THR 210 CONFLICT SEQRES 1 A 358 MET SER TYR TYR HIS HIS HIS HIS HIS HIS ASP TYR ASP SEQRES 2 A 358 ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA ALA SEQRES 3 A 358 PRO ALA ASP PRO GLY LYS ALA GLY VAL PRO GLY VAL ALA SEQRES 4 A 358 ALA PRO GLY ALA PRO ALA ALA ALA PRO PRO ALA LYS GLU SEQRES 5 A 358 ILE PRO GLU VAL LEU VAL ASP PRO ARG SER ARG ARG ARG SEQRES 6 A 358 TYR VAL ARG GLY ARG PHE LEU GLY LYS GLY GLY PHE ALA SEQRES 7 A 358 LYS CYS PHE GLU ILE SER ASP ALA ASP THR LYS GLU VAL SEQRES 8 A 358 PHE ALA GLY LYS ILE VAL PRO LYS SER LEU LEU LEU LYS SEQRES 9 A 358 PRO HIS GLN ARG GLU LYS MET SER MET GLU ILE SER ILE SEQRES 10 A 358 HIS ARG SER LEU ALA HIS GLN HIS VAL VAL GLY PHE HIS SEQRES 11 A 358 GLY PHE PHE GLU ASP ASN ASP PHE VAL PHE VAL VAL LEU SEQRES 12 A 358 GLU LEU CYS ARG ARG ARG SER LEU LEU GLU LEU HIS LYS SEQRES 13 A 358 ARG ARG LYS ALA LEU THR GLU PRO GLU ALA ARG TYR TYR SEQRES 14 A 358 LEU ARG GLN ILE VAL LEU GLY CYS GLN TYR LEU HIS ARG SEQRES 15 A 358 ASN ARG VAL ILE HIS ARG ASP LEU LYS LEU GLY ASN LEU SEQRES 16 A 358 PHE LEU ASN GLU ASP LEU GLU VAL LYS ILE GLY ASP PHE SEQRES 17 A 358 GLY LEU ALA THR LYS VAL GLU TYR ASP GLY GLU ARG LYS SEQRES 18 A 358 LYS VAL LEU CYS GLY THR PRO ASN TYR ILE ALA PRO GLU SEQRES 19 A 358 VAL LEU SER LYS LYS GLY HIS SER PHE GLU VAL ASP VAL SEQRES 20 A 358 TRP SER ILE GLY CYS ILE MET TYR THR LEU LEU VAL GLY SEQRES 21 A 358 LYS PRO PRO PHE GLU THR SER CYS LEU LYS GLU THR TYR SEQRES 22 A 358 LEU ARG ILE LYS LYS ASN GLU TYR SER ILE PRO LYS HIS SEQRES 23 A 358 ILE ASN PRO VAL ALA ALA SER LEU ILE GLN LYS MET LEU SEQRES 24 A 358 GLN THR ASP PRO THR ALA ARG PRO THR ILE ASN GLU LEU SEQRES 25 A 358 LEU ASN ASP GLU PHE PHE THR SER GLY TYR ILE PRO ALA SEQRES 26 A 358 ARG LEU PRO ILE THR CYS LEU THR ILE PRO PRO ARG PHE SEQRES 27 A 358 SER ILE ALA PRO SER SER LEU ASP PRO SER ASN ARG LYS SEQRES 28 A 358 PRO LEU THR VAL LEU ASN LYS HET ZN A 401 1 HET 79C A 402 39 HETNAM ZN ZINC ION HETNAM 79C 4-[(9-CYCLOPENTYL-7,7-DIFLUORO-5-METHYL-6-OXO-6,7,8,9- HETNAM 2 79C TETRAHYDRO-5H-PYRIMIDO[4,5-B][1,4]DIAZEPIN-2-YL) HETNAM 3 79C AMINO]-3-METHOXY-N-(1-METHYLPIPERIDIN-4-YL)BENZAMIDE FORMUL 2 ZN ZN 2+ FORMUL 3 79C C27 H35 F2 N7 O3 FORMUL 4 HOH *43(H2 O) HELIX 1 AA1 SER A 87 LEU A 89 5 3 HELIX 2 AA2 LYS A 91 LEU A 108 1 18 HELIX 3 AA3 SER A 137 LYS A 146 1 10 HELIX 4 AA4 THR A 149 ASN A 170 1 22 HELIX 5 AA5 LYS A 178 GLY A 180 5 3 HELIX 6 AA6 ALA A 219 LYS A 225 1 7 HELIX 7 AA7 PHE A 230 GLY A 247 1 18 HELIX 8 AA8 CYS A 255 LYS A 265 1 11 HELIX 9 AA9 ASN A 275 LEU A 286 1 12 HELIX 10 AB1 ASP A 289 ARG A 293 5 5 HELIX 11 AB2 THR A 295 ASN A 301 5 7 HELIX 12 AB3 ASP A 302 SER A 307 1 6 HELIX 13 AB4 PRO A 315 THR A 320 5 6 SHEET 1 AA1 6 VAL A 43 ASP A 46 0 SHEET 2 AA1 6 ARG A 51 GLY A 60 -1 O TYR A 53 N LEU A 44 SHEET 3 AA1 6 LYS A 66 ASP A 72 -1 O GLU A 69 N GLY A 56 SHEET 4 AA1 6 VAL A 78 PRO A 85 -1 O PHE A 79 N ILE A 70 SHEET 5 AA1 6 PHE A 125 LEU A 130 -1 O LEU A 130 N ALA A 80 SHEET 6 AA1 6 PHE A 116 GLU A 121 -1 N PHE A 120 O PHE A 127 SHEET 1 AA2 2 VAL A 172 ILE A 173 0 SHEET 2 AA2 2 THR A 199 LYS A 200 -1 O THR A 199 N ILE A 173 SHEET 1 AA3 2 LEU A 182 LEU A 184 0 SHEET 2 AA3 2 VAL A 190 ILE A 192 -1 O LYS A 191 N PHE A 183 LINK SG CYS A 212 ZN ZN A 401 1555 1555 2.01 LINK SG CYS A 255 ZN ZN A 401 1555 6555 2.59 SITE 1 AC1 4 HIS A 93 CYS A 212 CYS A 255 HOH A 505 SITE 1 AC2 13 PHE A 58 LEU A 59 CYS A 67 GLU A 69 SITE 2 AC2 13 ALA A 80 VAL A 114 LEU A 130 GLU A 131 SITE 3 AC2 13 LEU A 132 CYS A 133 ARG A 134 ARG A 136 SITE 4 AC2 13 PHE A 183 CRYST1 67.364 67.364 151.918 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014845 0.008571 0.000000 0.00000 SCALE2 0.000000 0.017141 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006582 0.00000